Your browser doesn't support javascript.
loading
Safety and efficacy of granulocyte colony-stimulating factor biosimilars in engraftment after autologous stem cell transplantation for haematological malignancies: a 4-year, single institute experience with different conditioning regimens.
Bassi, Simona; Stroppa, Elisa M; Moroni, Carlo F; Arbasi, Maria C; Trabacchi, Elena; Di Franco, Anna; Lazzaro, Antonio; Bernuzzi, Patrizia; Moretto, Mauro; Arcari, Annalisa; Bosi, Costanza; Riva, Alessandra; Cavanna, Luigi; Vallisa, Daniele.
Afiliación
  • Bassi S; Haematology Unit and Bone Marrow Transplant Centre, "Guglielmo da Saliceto" Hospital, Piacenza, Italy.
  • Stroppa EM; Oncology Unit, "Guglielmo da Saliceto" Hospital, Piacenza, Italy.
  • Moroni CF; Haematology Unit and Bone Marrow Transplant Centre, "Guglielmo da Saliceto" Hospital, Piacenza, Italy.
  • Arbasi MC; Immunohaematology and Transfusion Medicine, "Guglielmo da Saliceto" Hospital, Piacenza, Italy.
  • Trabacchi E; Haematology Unit and Bone Marrow Transplant Centre, "Guglielmo da Saliceto" Hospital, Piacenza, Italy.
  • Di Franco A; Immunohaematology and Transfusion Medicine, "Guglielmo da Saliceto" Hospital, Piacenza, Italy.
  • Lazzaro A; Haematology Unit and Bone Marrow Transplant Centre, "Guglielmo da Saliceto" Hospital, Piacenza, Italy.
  • Bernuzzi P; Haematology Unit and Bone Marrow Transplant Centre, "Guglielmo da Saliceto" Hospital, Piacenza, Italy.
  • Moretto M; Immunohaematology and Transfusion Medicine, "Guglielmo da Saliceto" Hospital, Piacenza, Italy.
  • Arcari A; Haematology Unit and Bone Marrow Transplant Centre, "Guglielmo da Saliceto" Hospital, Piacenza, Italy.
  • Bosi C; Haematology Unit and Bone Marrow Transplant Centre, "Guglielmo da Saliceto" Hospital, Piacenza, Italy.
  • Riva A; Antiblastic Drugs Unit and Pharmacy, "Guglielmo da Saliceto" Hospital, Piacenza, Italy.
  • Cavanna L; Oncology Unit, "Guglielmo da Saliceto" Hospital, Piacenza, Italy.
  • Vallisa D; Haematology Unit and Bone Marrow Transplant Centre, "Guglielmo da Saliceto" Hospital, Piacenza, Italy.
Blood Transfus ; 13(3): 478-83, 2015 Jul.
Article en En | MEDLINE | ID: mdl-25761321
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Trasplante de Células Madre Hematopoyéticas / Acondicionamiento Pretrasplante / Biosimilares Farmacéuticos / Filgrastim / Linfoma / Mieloma Múltiple Tipo de estudio: Guideline / Health_economic_evaluation / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Blood Transfus Año: 2015 Tipo del documento: Article País de afiliación: Italia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Trasplante de Células Madre Hematopoyéticas / Acondicionamiento Pretrasplante / Biosimilares Farmacéuticos / Filgrastim / Linfoma / Mieloma Múltiple Tipo de estudio: Guideline / Health_economic_evaluation / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Blood Transfus Año: 2015 Tipo del documento: Article País de afiliación: Italia